Soft Tissue Sarcoma
📧 Sign up to get email alerts when something new happens for Soft Tissue Sarcoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-03-06Clinical Trial Update: Efficacy and Safety Assessment of Oral LBH589 in Adult Patients With Advanced Soft TIssue Sarcoma After Pre-treatment Failure [Phase 2]
Phase 2 trial evaluating oral panobinostat (LBH589) for efficacy and safety in adults with advanced soft tissue sarcoma after prior treatmen…
-
CLINICAL_TRIALS trial_result · 2013-02-28Clinical Trial Update: Imatinib Mesylate in Treating Patients With Locally Recurrent or Metastatic Dermatofibrosarcoma Protuberans [Phase 2]
Phase 2 trial evaluating imatinib mesylate in patients with locally recurrent or metastatic dermatofibrosarcoma protuberans.
-
CLINICAL_TRIALS research · 2013-02-15Clinical Trial Update: Vaccine Therapy and Sargramostim in Treating Patients With Soft Tissue Sarcoma [Phase 1]
Phase 1 trial evaluating a vaccine therapy in combination with sargramostim for soft tissue sarcoma was terminated.
-
CLINICAL_TRIALS trial_result · 2013-02-11Clinical Trial Update: SU5416 in Treating Patients With Advanced, Metastatic, or Recurrent Soft Tissue Sarcomas [Phase 2]
A Phase 2 study of SU5416 in patients with advanced, metastatic, or recurrent soft tissue sarcomas, including gastrointestinal stromal tumor…
-
CLINICAL_TRIALS trial_result · 2013-02-08Clinical Trial Update: Dolastatin 10 in Treating Patients With Recurrent or Metastatic Soft Tissue Sarcoma [Phase 2]
Phase 2 trial update showing Dolastatin 10 in patients with recurrent or metastatic soft tissue sarcoma has completed; ovarian cancer is lis…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-02-07Clinical Trial Update: 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Advanced Epithelial Cancer, Malignant Lymphoma, or Sarcoma [Phase 1]
This Phase 1 trial evaluated the Hsp90 inhibitor tanespimycin (17-AAG) in patients with advanced epithelial cancers, malignant lymphomas, or…
-
FDA approval · 2013-02-04FDA Approved: DOXORUBICIN HYDROCHLORIDE — Original Application (BluePoint Laboratories)
FDA approved a generic doxorubicin hydrochloride product under Original Application for BluePoint Laboratories (ANDA 203263). This marks app…
-
CLINICAL_TRIALS trial_result · 2013-01-16Clinical Trial Update: Isolated Limb Infusion of Chemotherapy in Treating Patients With Melanoma or Soft Tissue Sarcoma of the Arm or Leg That Cannot Be Removed By Surgery [Phase 2]
Phase 2 trial assessing isolated limb infusion of chemotherapy for patients with melanoma or soft tissue sarcoma of the arm or leg that cann…
-
CLINICAL_TRIALS other · 2013-01-16Clinical Trial Update: EF5 to Evaluate Tumor Hypoxia in Patients With High-Grade Soft Tissue Sarcoma or Mouth Cancer [NA]
A trial evaluating EF5 as a biomarker of tumor hypoxia in high-grade soft tissue sarcoma and squamous cell carcinoma of the lip/oral cavity …
-
CLINICAL_TRIALS trial_result · 2013-01-10Clinical Trial Update: A Safety Study Utilizing Yondelis and Doxorubicin in Patients With a Type of Cancer Called Soft Tissue Sarcoma [Phase 1]
A Phase 1 safety study evaluating the combination of Yondelis (trabectedin) and doxorubicin in patients with soft tissue sarcoma.
-
CLINICAL_TRIALS trial_result · 2013-01-08Clinical Trial Update: Trofosfamide Versus Adriamycin in Elderly Patients With Soft Tissue Sarcoma (STS) [Phase 2]
A phase 2 trial comparing trofosfamide to Adriamycin in elderly patients with soft tissue sarcoma; the current status is UNKNOWN.
-
CLINICAL_TRIALS trial_result · 2012-12-18Clinical Trial Update: Interaction of Docetaxel and Lonafarnib in Patients With Advanced Cancer [Phase 1]
A Phase 1 trial evaluating the interaction of docetaxel and lonafarnib in patients with advanced cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2012-11-01Clinical Trial Update: S0505 Sorafenib in Treating Patients With Advanced Soft Tissue Sarcomas [Phase 2]
Phase 2 trial S0505 evaluated sorafenib in patients with advanced soft tissue sarcoma; the study has completed and results were posted in 20…
-
CLINICAL_TRIALS trial_result · 2012-09-24Clinical Trial Update: Ecteinascidin 743 in Treating Patients With Advanced Soft Tissue Sarcoma [Phase 2]
Phase 2 trial results update for Ecteinascidin-743 (trabectedin) in patients with advanced soft tissue sarcoma; the study status is complete…
-
CLINICAL_TRIALS trial_result · 2012-09-24Clinical Trial Update: STI571 in Treating Patients With Recurrent or Refractory Soft Tissue Sarcoma [Phase 1, Phase 2]
Phase 1/2 trial update of STI571 (imatinib) in patients with recurrent or refractory soft tissue sarcoma; the study status is reported as co…
-
CLINICAL_TRIALS trial_result · 2012-09-24Clinical Trial Update: Liposomal Doxorubicin Plus Ifosfamide in Treating Patients With Advanced or Metastatic Soft Tissue Sarcoma [Phase 1]
A Phase 1 clinical trial evaluating liposomal doxorubicin plus ifosfamide for advanced or metastatic soft tissue sarcoma has completed.
-
CLINICAL_TRIALS trial_result · 2012-09-18Clinical Trial Update: Conformal Radiation Therapy in Treating Patients With Metastatic Cancer Outside the Brain [Phase 2]
A Phase 2 clinical trial evaluating conformal radiation therapy for metastatic cancers outside the brain was terminated, with results posted…
-
CLINICAL_TRIALS trial_result · 2012-09-06Clinical Trial Update: Efficacy and Safety Evaluation of Pegamotecan (PEG-camptothecin) in Advanced or Metastatic Soft Tissue Sarcoma [Phase 2]
Phase 2 study evaluating the efficacy and safety of pegamotecan in advanced or metastatic soft tissue sarcoma has been suspended. Enrollment…
-
CLINICAL_TRIALS trial_result · 2012-08-02Clinical Trial Update: Doxorubicin Plus External-Beam Radiation Therapy in Treating Patients With Soft Tissue Sarcoma [Phase 1]
A Phase 1 trial investigated combining doxorubicin with external-beam radiation therapy for soft tissue sarcoma. The study is completed.
-
CLINICAL_TRIALS withdrawal · 2012-08-01Clinical Trial Update: Functional Outcomes Following Limb Sparing Surgery for Sarcoma Patients
A clinical trial studying functional outcomes after limb-sparing surgery for sarcoma patients has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2012-07-30Clinical Trial Update: Radiation Therapy Plus Doxorubicin in Treating Patients With Resectable Primary or Recurrent Retroperitoneal Soft Tissue Sarcoma [Phase 1]
Phase 1 trial evaluating the safety and feasibility of combining radiation therapy with doxorubicin in patients with resectable primary or r…
-
CLINICAL_TRIALS trial_result · 2012-07-18Clinical Trial Update: Brostallicin in Treating Patients With Locally Advanced or Metastatic Soft Tissue Sarcoma [Phase 2]
A Phase 2 study evaluating brostallicin in patients with locally advanced or metastatic soft tissue sarcoma has completed.
-
CLINICAL_TRIALS trial_result · 2012-07-18Clinical Trial Update: Exatecan Mesylate in Treating Patients With Advanced Soft Tissue Sarcoma [Phase 2]
This clinical trial update reports on a Phase 2 study of exatecan mesylate in patients with advanced soft tissue sarcoma, with the study sta…
-
CLINICAL_TRIALS trial_result · 2012-07-16Clinical Trial Update: The Biological Activity of Cediranib (AZD2171) in Gastro-Intestinal Stromal Tumours(GIST). [Phase 2]
Phase 2 study evaluating the biological activity of cediranib (AZD2171) in gastrointestinal stromal tumors and related soft tissue sarcomas;…
-
CLINICAL_TRIALS withdrawal · 2012-07-12Clinical Trial Update: Study of Oral Ridaforolimus in Combination With Standard Chemotherapy for Soft Tissue Sarcoma [Phase 1]
A Phase 1 study of ridaforolimus in combination with standard chemotherapy for soft tissue sarcoma has been withdrawn.